WCN25-714 EXAMINING RADIOACTIVE IODINE’S THERAPEUTIC LANDSCAPE IN DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS, A CASE SERIES

There are limited publications that shed light on the management of patients who undergo Radioactive Iodine (RAI) while on hemodialysis. As the number of patients undergoing dialysis grows, we see more patients with different co-morbidities such as those needing RAI. Radioactive Iodine is used to treat patients with thyroid cancer and since excretion is primarily through renal clearance, management of patients undergoing treatment and dialysis poses a challenge. Currently, no standardized guidelines exist regarding the administration of RAI dosing and the timing of dialysis in this specific population.